award

Cancer-focused CorriXR Therapetics wins ‘most promising’ award

Betsy PriceBusiness, Headlines

CorriXR Therapeutics was given the “Most Promising New Company” award by attendees at the inaugural Delaware’s DNA 2023 Life Science Conference. Sponsored by Delaware Bio, the conference attracted 300 people to network and hear panels about industry trends. CorriXR, the first spin-out of ChristianaCare’s Gene Editing Institute, is an oncology-focused biotherapeutics development company with what they describe as a ground-breaking …